Antistoffer før dosering blev påvist hos 5 af 636 patienter (< 1%) og 16/ 635 patienter (2, 5%), der var testet vha. henholdsvis ELISA og biosensor- immunoanalysen.
Pre-dose antibodies were detected in 5 of 636 patients (< 1%) and 16/ 635 patients (2.5%) tested by the ELISA and Biosensor Immunoassay respectively.